Rush University Medical Center - Cancer Center

1653 West Congress Parkway
Chicago, Illinois 60612

We've found

1 trials

at this facility

A Study of Parsaclisib in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!